Botulinum toxin type A for treating upper or lower limb focal spasticity associated with stroke [ID768]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Cannabis-based medicinal products (NG144)Product type:GuidanceProgramme:NICE guidelineLast updated: 22 March 2021Published: 11 November 2019
Mollii suit for spasticity (MIB100)Product type:AdviceProgramme:Medtech innovation briefingPublished: 28 March 2017
Selective dorsal rhizotomy for spasticity in cerebral palsy (IPG373)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 15 December 2010
Spasticity in under 19s: management (CG145)Product type:GuidanceProgramme:Clinical guidelineLast updated: 29 November 2016Published: 25 July 2012
Xeomin (botulinum neurotoxin type A) for treating lower limb spasticity TS ID 11902Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC